HRIA
ORMP icon

Haberer Registered Investment Advisor’s Oramed Pharmaceuticals ORMP Stock Holding History

Haberer Registered Investment Advisor’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-334
Closed -$2K – 319
2014
Q4 		$2K Hold
334
– – ﹤0.01% 297
2014
Q3 		$3K Hold
334
– – ﹤0.01% 354
2014
Q2 		$3K Hold
334
– – ﹤0.01% 370
2014
Q1 		$4K Hold
334
– – ﹤0.01% 333
2013
Q4 		$5K Hold
334
– – ﹤0.01% 324
2013
Q3 		$2K Hold
334
– – ﹤0.01% 402
2013
Q2 		$3K Buy
+334
New +$2.75K ﹤0.01% 416

Other funds holding ORMP

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Haberer Registered Investment Advisor's ORMP Position: Q1 2015 in Review

Haberer Registered Investment Advisor sold out of Oramed Pharmaceuticals (ORMP) in Q1 2015, closing a stake of 334 shares — an estimated $2K sold.

Haberer Registered Investment Advisor first reported a position in ORMP in Q2 2013 and held it in 7 quarters. The position peaked at $5K in Q4 2013. 17 funds tracked by Wall St. Rank hold ORMP as of Q1 2015.

  • Haberer Registered Investment Advisor reported no remaining Oramed Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Haberer Registered Investment Advisor sold 334 Oramed Pharmaceuticals shares in Q1 2015, an estimated $2K.
  • Haberer Registered Investment Advisor first reported a position in Oramed Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Haberer Registered Investment Advisor's Oramed Pharmaceuticals position peaked at $5K in Q4 2013.
  • 17 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2015.

Based on Haberer Registered Investment Advisor's 13F filing for Q1 2015, filed 8 Apr 2015.